P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood–brain barrier

References

• Avdeef A, Barrett DA, Shaw PN, Knaggs RD, Davis SS. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J Med Chem 1996; 39: 4377–4381
   PubMed Web of Science ®Google Scholar
• Boström E, Simonsson US, Hammarlund-Udenaes M. Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833. J Pharm Sci 2005; 94: 1060–1066
   PubMed Web of Science ®Google Scholar
• Bullingham RE, McQuay HJ, Moore A, Bennett MR. Buprenorphine kinetics. Clin Pharmacol Ther 1980; 28: 667–672
   PubMed Web of Science ®Google Scholar
• Callaghan R, Riordan JR. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem 1993; 268: 16059–16064
   PubMed Web of Science ®Google Scholar
• Chikhale EG, Ng KY, Burton PS, Borchardt RT. Hydrogen bonding potential as a determinant of the in vitro and in situ blood–brain barrier permeability of peptides. Pharm Res 1994; 11: 412–419
   PubMed Web of Science ®Google Scholar
• Cook PJ, James IM, Hobbs KE, Browne DR. Controlled comparison of I.M. morphine and buprenorphine for analgesia after abdominal surgery. Br J Anaesth 1982; 54: 285–290
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–698
   PubMed Web of Science ®Google Scholar
• Dagenais C, Graff CL, Pollack GM. Variable modulation of opioid brain uptake by P-glycoprotein in mice. Biochem Pharmacol 2004; 67: 269–276
   PubMed Web of Science ®Google Scholar
• Downing JW, Leary WP, White ES. Buprenorphine: A new potent long-acting synthetic analgesic. Comparison with morphine. Br J Anaesth 1977; 49: 251–255
   PubMed Web of Science ®Google Scholar
• Garrett ER, Chandran VR. Pharmacokinetics of morphine and its surrogates VI: Bioanalysis, solvolysis kinetics, solubility, pK'a values, and protein binding of buprenorphine. J Pharm Sci 1985; 74: 515–524
   PubMed Web of Science ®Google Scholar
• Golden PL, Pollack GM. Blood–brain barrier efflux transport. J Pharm Sci 2003; 92: 1739–1753
   PubMed Web of Science ®Google Scholar
• Heel RC, Brogden RN, Speight TM, Avery GS. Buprenorphine: A review of its pharmacological properties and therapeutic efficacy. Drugs 1979; 17: 81–110
   PubMed Web of Science ®Google Scholar
• Henthorn TK, Liu Y, Mahapatro M, Ng KY. Active transport of fentanyl by the blood–brain barrier. J Pharmacol Exp Ther 1999; 289: 1084–1089
   PubMed Web of Science ®Google Scholar
• Kakee A, Terasaki T, Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood–brain barrier. J Pharmacol Exp Ther 1996; 277: 1550–1559
   PubMed Web of Science ®Google Scholar
• Kay B. A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation. Br J Anaesth 1978; 50: 605–609
   PubMed Web of Science ®Google Scholar
• King M, Su W, Chang A, Zuckerman A, Pasternak GW. Transport of opioids from the brain to the periphery by P-glycoprotein: Peripheral actions of central drugs. Nat Neurosci 2001; 4: 268–274
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Sugiyama Y. Efflux transport systems for drugs at the blood–brain barrier and blood-cerebrospinal fluid barrier (Part 1). Drug Discov Today 2001; 6: 150–156
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Sugiyama Y. Active efflux across the blood–brain barrier: Role of the solute carrier family. NeuroRx 2005; 2: 73–85
   PubMedGoogle Scholar
• Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, Sugiyama Y. P-Glycoprotein mediates the efflux of quinidine across the blood–brain barrier. J Pharmacol Exp Ther 1997; 283: 574–580
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Terasaki T, Sugiyama Y. Brain efflux index method. Characterization of efflux transport across the blood–brain barrier. Methods Mol Med 2003; 89: 219–231
   PubMedGoogle Scholar
• Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 1980; 23: 682–684
   PubMed Web of Science ®Google Scholar
• Moriki Y, Suzuki T, Fukami T, Hanano M, Tomono K, Watanabe J. Involvement of P-glycoprotein in blood–brain barrier transport of pentazocine in rats using brain uptake index method. Biol Pharm Bull 2004; 27: 932–935
   PubMed Web of Science ®Google Scholar
• Moriki Y, Suzuki T, Furuishi T, Fukami T, Tomono K, Watanabe J. In vivo evidence for the efflux transport of pentazocine from the brain across the blood–brain barrier using the brain efflux index method. J Drug Target 2005; 13: 53–59
   PubMed Web of Science ®Google Scholar
• Newman GC, Hospod FE, Schissel SL. Ischemic brain slice glucose utilization: Effects of slice thickness, acidosis, and K+. J Cereb Blood Flow Metab 1991; 11: 398–406
   PubMed Web of Science ®Google Scholar
• Ohtani M, Kotaki H, Sawada Y, Iga T. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 1995; 272: 505–510
   PubMed Web of Science ®Google Scholar
• Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J Pharmacol Exp Ther 1997; 281: 428–433
   PubMed Web of Science ®Google Scholar
• Oldendolf WH. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res 1970; 24: 372–376
   PubMedGoogle Scholar
• Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 1981; 2: 103–123
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Blood–brain barrier biology and methodology. J Neurovirol 1999; 5: 556–569
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Fierer G. Blood–brain barrier transport of butanol and water relative to N-isopropyl-p-iodoamphetamine as the internal reference. J Cereb Blood Flow Metab 1985; 5: 275–281
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Ortega I, Soengas I, Suarez E, Lukas JC, Calvo R. Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat. J Pharm Pharmacol 2004; 56: 367–374
   PubMed Web of Science ®Google Scholar
• Schinkel AH. P-Glycoprotein, a gatekeeper in the blood–brain barrier. Adv Drug Deliv Rev 1999; 36: 179–194
   PubMed Web of Science ®Google Scholar
• Sun H, Dai H, Shaik N, Elmquist WF. Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003; 55: 83–105
   PubMed Web of Science ®Google Scholar
• Suzuki T, Oshimi M, Tomono K, Hanano M, Watanabe J. Investigation of transport mechanism of pentazocine across the blood–brain barrier using the in situ rat brain perfusion technique. J Pharm Sci 2002a; 91: 2346–2353
   PubMed Web of Science ®Google Scholar
• Suzuki T, Moriki Y, Goto H, Tomono K, Hanano M, Watanabe J. Investigation on the influx transport mechanism of pentazocine at the blood–brain barrier in rats using the carotid injection technique. Biol Pharm Bull 2002b; 25: 1351–1355
   PubMed Web of Science ®Google Scholar
• Tatsuta T, Naito M, Oh-hara T, Sugawara I, Tsuruo T. Functional involvement of P-glycoprotein in blood–brain barrier. J Biol Chem 1992; 267: 20383–20391
   PubMed Web of Science ®Google Scholar
• Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 1989; 37: 159–164
   PubMed Web of Science ®Google Scholar
• Thompson SJ, Koszdin K, Bernards CM. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 2000; 92: 1392–1399
   PubMed Web of Science ®Google Scholar
• Tsuji A, Tamai I. Blood–brain barrier function of P-glycoprotein. Adv Drug Deliv Rev 1997; 25: 287–298
   Web of Science ®Google Scholar
• Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 2002; 96: 913–920
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 1981; 4: 879–885
   PubMedGoogle Scholar
• Zong J, Pollack GM. Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharm Res 2000; 17: 749–753
   PubMed Web of Science ®Google Scholar